Trials / Completed
CompletedNCT04975022
A Study Evaluating the Bioavailability of Oral Insulin (N11005)
Research on Clinical Application of New Therapies for Diabetes and Its Complications and Related Translational Medicine Research
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 12 (actual)
- Sponsor
- Beijing Hospital · Other Government
- Sex
- Male
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
The objective of this study was to preliminarily verify whether the oral insulin N11005 is a prandial insulin by assessing the PK, PD, and safety profiles of N11005.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | N11005 | oral insulin N11005, 300IU, p.o. |
| DRUG | Novolin R | reference preparation Novolin R, 0.1 IU/Kg, i.h. |
Timeline
- Start date
- 2019-12-10
- Primary completion
- 2020-08-14
- Completion
- 2020-08-14
- First posted
- 2021-07-23
- Last updated
- 2021-07-28
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT04975022. Inclusion in this directory is not an endorsement.